Showing results (481-490 of 561) with videos related to
Sort By:
Pageof 57
Anticancer Research|October 3, 2014
First-line treatment result influence second-line regimen selection in targeted therapy for metastatic renal cell carcinomaJian-Ri Li, Cheng-Kuang Yang, Shian-Shiang Wang, et al.Urologic Oncology|March 3, 2019
Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survivalSheng-Chun Hung, Shian-Shiang Wang, Jian-Ri Li, et al.Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|April 13, 2017
Ureteroscopy-Assisted Laparoscopic Segmental Resection of Ureteral Stricture with a Modified Flank Position: Clinical ExperienceSheng-Chun Hung, Kun-Yuan Chiu, Chen-Li Cheng, et al.Journal of the Chinese Medical Association : JCMA|May 29, 2012
Renal mucinous tubular and spindle cell carcinoma with an aorto-caval mass mimicking metastatic lymphadenopathyChien-Chang Li, Chen-Hui Lee, Yee-Jee Jan, et al.Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.Frontiers in Pharmacology|March 17, 2022
Integrated UPLC-MS and Network Pharmacology Approach to Explore the Active Components and the Potential Mechanism of Yiqi Huoxue Decoction for Treating Nephrotic SyndromeDan Feng, Xiang-Ri Li, Zhao-Yi Wang, et al.International Journal of Molecular Sciences|June 12, 2019
Fibronectin Promotes Cell Growth and Migration in Human Renal Cell Carcinoma CellsYen-Chuan Ou, Jian-Ri Li, Jiaan-Der Wang, et al.Anticancer Research|July 3, 2019
Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center ExperienceLi-Wen Chang, Sheng-Chun Hung, Shian-Shiang Wang, et al.Wilderness & Environmental Medicine|July 29, 2015
Oxidized Low Density Lipoprotein Among the Elderly in Qinghai-Tibet PlateauRyota Sakamoto, Kiyohito Okumiya, Hongxin Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, et al.Pageof 57